Cottonwood Capital Advisors LLC Has $218,000 Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Cottonwood Capital Advisors LLC cut its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 41.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,405 shares of the company’s stock after selling 2,438 shares during the period. Cottonwood Capital Advisors LLC’s holdings in Ryan Specialty were worth $218,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently made changes to their positions in RYAN. Vanguard Personalized Indexing Management LLC bought a new stake in shares of Ryan Specialty in the 2nd quarter valued at about $248,000. Thrivent Financial for Lutherans lifted its position in shares of Ryan Specialty by 519.6% in the second quarter. Thrivent Financial for Lutherans now owns 28,803 shares of the company’s stock valued at $1,668,000 after buying an additional 24,154 shares during the last quarter. ProShare Advisors LLC bought a new position in shares of Ryan Specialty during the 2nd quarter worth approximately $280,000. Xponance Inc. increased its holdings in shares of Ryan Specialty by 67.2% during the 2nd quarter. Xponance Inc. now owns 20,686 shares of the company’s stock worth $1,198,000 after acquiring an additional 8,312 shares during the last quarter. Finally, AQR Capital Management LLC bought a new stake in Ryan Specialty in the 2nd quarter valued at $261,000. Institutional investors and hedge funds own 84.82% of the company’s stock.

Insiders Place Their Bets

In other Ryan Specialty news, Director David P. Bolger sold 7,055 shares of the stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $70.88, for a total value of $500,058.40. Following the completion of the transaction, the director now directly owns 78,149 shares in the company, valued at approximately $5,539,201.12. This trade represents a 8.28 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Nicholas Dominic Cortezi sold 29,466 shares of the company’s stock in a transaction that occurred on Monday, January 13th. The shares were sold at an average price of $65.06, for a total value of $1,917,057.96. Following the completion of the transaction, the director now directly owns 45,409 shares of the company’s stock, valued at $2,954,309.54. This represents a 39.35 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 271,887 shares of company stock valued at $18,118,273. 11.10% of the stock is currently owned by corporate insiders.

Ryan Specialty Price Performance

Shares of NYSE:RYAN opened at $63.27 on Friday. The firm has a 50 day moving average of $67.34 and a 200-day moving average of $66.14. Ryan Specialty Holdings, Inc. has a 12 month low of $42.21 and a 12 month high of $75.97. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The stock has a market capitalization of $16.57 billion, a PE ratio of 82.16, a PEG ratio of 1.14 and a beta of 0.72.

Ryan Specialty (NYSE:RYAN) last released its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, hitting the consensus estimate of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The firm had revenue of $604.69 million during the quarter, compared to analysts’ expectations of $602.04 million. During the same period in the prior year, the company earned $0.32 earnings per share. The company’s quarterly revenue was up 20.5% on a year-over-year basis. On average, equities research analysts predict that Ryan Specialty Holdings, Inc. will post 1.82 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th were given a $0.11 dividend. This represents a $0.44 dividend on an annualized basis and a yield of 0.70%. The ex-dividend date of this dividend was Tuesday, November 12th. Ryan Specialty’s dividend payout ratio is presently 57.14%.

Analysts Set New Price Targets

RYAN has been the topic of several research reports. Keefe, Bruyette & Woods decreased their price objective on shares of Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating on the stock in a report on Friday, January 10th. Bank of America increased their price target on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a report on Thursday, October 10th. Morgan Stanley began coverage on Ryan Specialty in a report on Thursday, December 5th. They set an “overweight” rating and a $90.00 price objective for the company. Barclays increased their target price on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, November 21st. Finally, Wells Fargo & Company reduced their price target on Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 14th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $74.40.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.